Follow-On Biologics' Other Pathway: Mechanisms To Resolve Patent Disputes Vary In Legislation

The debate over follow-on biologics legislation has largely focused on the length of data exclusivity that should be awarded to innovators. But provisions for resolving patent disputes between innovators and follow-on applicants are also a source of contention